265 related articles for article (PubMed ID: 11123087)
1. Clinical value of antineutrophil cytoplasmic antibodies.
Rus V; Handwerger BS
Curr Rheumatol Rep; 2000 Oct; 2(5):383-9. PubMed ID: 11123087
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasm antibody: positivity and clinical correlation.
Martínez Téllez G; Torres Rives B; Rangel Velázquez S; Sánchez Rodríguez V; Ramos Ríos MA; Fuentes Smith LE
Reumatol Clin; 2015; 11(1):17-21. PubMed ID: 24913965
[TBL] [Abstract][Full Text] [Related]
4. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
5. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
[TBL] [Abstract][Full Text] [Related]
6. [Use of autoantibodies in clinical practice].
Petitpierre S; Aubert V; Leimgruber A; Spertini F; Bart PA
Rev Med Suisse; 2009 Apr; 5(199):823-31. PubMed ID: 19441748
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitides--immunologic and clinical aspects.
Schulz JI
Bratisl Lek Listy; 1995 Oct; 96(10):520-2. PubMed ID: 8620321
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
9. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
10. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Gross WL
Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
[TBL] [Abstract][Full Text] [Related]
12. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis.
Wiesner O; Russell KA; Lee AS; Jenne DE; Trimarchi M; Gregorini G; Specks U
Arthritis Rheum; 2004 Sep; 50(9):2954-65. PubMed ID: 15457464
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
Schultz DR; Diego JM
Semin Arthritis Rheum; 2000 Apr; 29(5):267-85. PubMed ID: 10805352
[TBL] [Abstract][Full Text] [Related]
15. The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis.
Luxton G; Langham R;
Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S17-23. PubMed ID: 18713120
[No Abstract] [Full Text] [Related]
16. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
18. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
20. [The significance of fluorescent patterns of antineutrophil cytoplasmic antibodies (ANCA) in renal diseases].
Xu YQ; Chen W; Li ZJ; Liu XS; Wang HM; Zhao J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Mar; 19(2):185-6. PubMed ID: 15151763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
